Enter OTP
Maisons-Alfort, France
Cost Of Living
Undergraduate Fees International Students
Post Graduate Fees International Students
The below information is required while
completing the university application :
Key documents typically required for admission into the Bachelor’s program at École Nationale Vétérinaire d’Alfort (ENVA):
High School Diploma or Equivalent
Proof that you’ve successfully completed secondary education, preferably with a science focus (biology, chemistry, physics).
Academic Transcripts
Detailed marksheets from your last three years of school, showing performance in science and general subjects.
Proof of French Language Proficiency
Since most undergraduate programs are taught in French, you’ll need DELF B2, DALF C1, or TCF scores to show your language level.
Curriculum Vitae (CV)
A concise 1-page CV highlighting your education, extracurriculars, volunteer experience (especially in animal care), and academic interests.
Motivation Letter
A letter explaining why you want to study veterinary medicine, why ENVA, and what you hope to achieve in your career.
Passport or National ID Copy
An official identification document for verification purposes.
If you're planning to apply and want help writing the motivation letter or building a strong CV, just say the word.
Know more
In recent ranking and institutional reviews, ENVA’s teaching hospital (CHUVA) has been identified as one of Europe’s most active veterinary hospitals, serving tens of thousands of cases annually across companion animals, equines, livestock, and wildlife. With around 35,000 procedures a year, 24/7 services, and integrated training and research platforms, ENVA demonstrates how clinical excellence supports both learning and public service delivery
Between 1996 and 2013, ENVA produced landmark publications—like Guého et al. (1996) describing four new Malassezia species (854 citations), Badoual et al. (2013) on tumor-infiltrating T‑cells (571 citations), and Boulouis et al. (2005) on zoonotic Bartonella (468 citations). These high-impact studies highlight ENVA's research excellence in microbiology, immunology, veterinary internal medicine, and One Health collaborations
Emmanuel Leclainche, graduated from ENVA and active in the early 20th century, spearheaded efforts that led to creation of the Office International des Épizooties (later OIE) in the 1920s. This global body coordinates international animal health responses, disease monitoring, and trade regulation. His vision, rooted in veterinary science and global health, helped form one of the key institutions for coordinated epidemic prevention worldwide
Since 2016, through DIM‑1HEALTH, ENVA co‑developed vaccine strategies with an integrated One‑Health lens combining animal, human, and environmental health. This initiative promotes new diagnostic frameworks, anti‑infective therapies, and social‑economic perspectives in prevention. Although not a patented single device, the program represents an ongoing innovation in vaccine design, epidemiological models, and translational therapeutics. ENVA’s role in the European “One Health” movement underscores its leadership in integrative research—bridging disciplines to address infectious threats from livestock to humans under changing climate and population pressures
On December 1 2015, ENVA co-held a patent for a bone substitute cement composed of calcium‑phosphate biomaterial combined with an analgesic agent. This invention targets bone‐filling in iliac crest defects, dental implants, or tissue engineering scaffolding. By blending osteoconductive cement with pain management, it offers integrated post‑operative relief and tissue regeneration. ENVA’s contribution reflects deep anatomical understanding, orthopedic knowledge, and biomaterials research. It opens possibilities in veterinary and human surgery, especially for repairing bone injuries where both structural support and analgesia are vital to recovery.
In 2013, researchers linked to ENVA co-invented identification methods for the human gyrovirus (HGyV), a virus structurally related to chicken anemia virus. They characterized HGyV proteins like H-apoptin and developed detection protocols potentially useful for cancer therapy or diagnostics. Though co‑assigned with Institut Pasteur, this patent—filed late 2011 and published early 2014—involved ENVA-based microbiological expertise and assay design. It represents ENVA’s translational reach into viral oncology and molecular virology. The work bridges veterinary virology, comparative pathogens, and emerging applications beyond classical animal health.
Embark on your educational journey with confidence! Our team of admission experts is here to guide you through the process. Book a free session now to receive personalized advice, assistance with applications, and insights into your dream school. Whether you're applying to college, graduate school, or specialized programs, we're here to help you succeed.
